Activation_NN
of_IN
the_DT
Janus_NN
kinase_NN
3-STAT5a_NN
pathway_NN
after_IN
CD40_NN
triggering_NN
of_IN
human_JJ
monocytes_NNS
but_CC
not_RB
of_IN
resting_VBG
B_NN
cells_NNS
._.

CD40\/CD40_NN
ligand_NN
interactions_NNS
play_VBP
a_DT
key_JJ
role_NN
in_IN
the_DT
immune_JJ
responses_NNS
of_IN
B_NN
lymphocytes_NNS
,_,
monocytes_NNS
,_,
and_CC
dendritic_JJ
cells_NNS
._.

The_DT
signal_NN
transduction_NN
events_NNS
triggered_VBN
by_IN
cross-linking_NN
of_IN
the_DT
CD40_NN
receptor_NN
have_VBP
been_VBN
widely_RB
studied_VBN
in_IN
B_NN
cell_NN
lines_NNS
,_,
but_CC
little_JJ
is_VBZ
known_VBN
about_IN
signaling_NN
following_VBG
CD40_NN
stimulation_NN
of_IN
monocytes_NNS
and_CC
resting_VBG
tonsillar_JJ
B_NN
cells_NNS
._.

Therefore_RB
,_,
we_PRP
studied_VBD
the_DT
CD40_NN
pathway_NN
in_IN
highly_RB
purified_VBN
human_JJ
monocytes_NNS
and_CC
resting_VBG
B_NN
cells_NNS
._.

After_IN
CD40_NN
triggering_NN
,_,
a_DT
similar_JJ
activation_NN
of_IN
the_DT
NF-kappaB_NN
-LRB-_-LRB-
but_CC
not_RB
of_IN
the_DT
AP-1_NN
-RRB-_-RRB-
transcription_NN
factor_NN
complex_NN
occurred_VBD
in_IN
both_DT
cell_NN
preparations_NNS
._.

However_RB
,_,
the_DT
components_NNS
of_IN
the_DT
NF-kappaB_NN
complexes_NNS
were_VBD
different_JJ
in_IN
monocytes_NNS
and_CC
B_NN
cells_NNS
,_,
because_IN
p50_NN
is_VBZ
part_NN
of_IN
the_DT
NF-kappaB_NN
complex_NN
induced_VBN
by_IN
CD40_NN
triggering_NN
in_IN
both_CC
monocytes_NNS
and_CC
B_NN
cells_NNS
,_,
whereas_IN
p65_NN
was_VBD
only_RB
induced_VBN
in_IN
B_NN
cells_NNS
._.

In_IN
contrast_NN
,_,
although_IN
the_DT
Janus_NN
kinase_NN
3_CD
tyrosine_NN
kinase_NN
was_VBD
associated_VBN
with_IN
CD40_NN
molecules_NNS
in_IN
both_CC
monocytes_NNS
and_CC
resting_VBG
B_NN
cells_NNS
,_,
Janus_NN
kinase_NN
3_CD
phosphorylation_NN
induction_NN
was_VBD
observed_VBN
only_RB
in_IN
CD40-activated_JJ
monocytes_NNS
,_,
with_IN
subsequent_JJ
induction_NN
of_IN
STAT5a_NN
DNA_NN
binding_NN
activity_NN
in_IN
the_DT
nucleus_NN
._.

These_DT
results_NNS
suggest_VBP
that_IN
the_DT
activation_NN
signals_NNS
in_IN
human_JJ
B_NN
cells_NNS
and_CC
monocytes_NNS
differ_VBP
following_VBG
CD40_NN
stimulation_NN
._.

This_DT
observation_NN
is_VBZ
consistent_JJ
with_IN
the_DT
detection_NN
of_IN
normal_JJ
CD40-induced_JJ
monocyte_NN
activation_NN
in_IN
patients_NNS
with_IN
CD40_NN
ligand_NN
+_CC
hyper_NN
IgM_NN
syndrome_NN
in_IN
whom_WP
a_DT
defect_NN
in_IN
CD40-induced_JJ
B_NN
cell_NN
activation_NN
has_VBZ
been_VBN
reported_VBN
._.

